{"id":"NCT00683930","sponsor":"Hoffmann-La Roche","briefTitle":"A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)","officialTitle":"A Prospective, Randomised, Double-blind, Placebo-controlled, Parallel Group, Mult-center, 52-week Trial to Assess the Efficacy and Safety of Adjunct Mycophenolate Mofetil (MMF) to Achieve Remission With Reduced Corticosteroid in Subjects With Pemphigus Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-05","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2008-05-26","resultsPosted":"2011-06-22","lastUpdate":"2011-06-22"},"enrollment":96,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pemphigus Vulgaris (PV)"],"interventions":[{"type":"DRUG","name":"Mycophenolate Mofetil 2 g/Day","otherNames":[]},{"type":"DRUG","name":"Mycophenolate Mofetil (MMF) 3 g/Day","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Mycophenolate Mofetil (MMF) 2 g/Day","type":"EXPERIMENTAL"},{"label":"Mycophenolate Mofetil (MMF) 3 g/Day","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study was designed to assess the efficacy and safety of CellCept (1 g or 1.5 g orally twice daily for 52 weeks) in patients with pemphigus vulgaris receiving prednisone or other corticosteroids. During the study, patients had their corticosteroid dose gradually reduced if they responded to treatment. The anticipated time on study treatment was 12 months, and the target sample size was \\<100 individuals.","primaryOutcome":{"measure":"Percentage of Patients Achieving Responder Status at Week 52","timeFrame":"52 weeks","effectByArm":[{"arm":"Placebo","deltaMin":63.9,"sd":null},{"arm":"MMF 2 g/Day and MMF 3 g/Day Groups Combined","deltaMin":69,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6558"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":26,"countries":["United States","Canada","Germany","Israel","Switzerland","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["20410913"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":36},"commonTop":["Pemphigus","Oral Candidiasis","Pyrexia","Hypertension","Headache"]}}